46
Participants
Start Date
September 30, 2001
Primary Completion Date
December 31, 2006
Study Completion Date
September 30, 2009
Temozolomide
Given once daily for 49 days followed by 28 days with no drug for a maximum of a year and a half
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Schering-Plough
INDUSTRY
Brigham and Women's Hospital
OTHER
University of Virginia
OTHER
Dana-Farber Cancer Institute
OTHER